Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 494 of 1,261

  1. US 10308909

    Dried spore germinative compound mixtures

    Envera LIC, LLC · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  2. US 10308720

    Multivalent and multispecific DR5-binding fusion proteins

    Inhibrx, Inc. · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  3. US 10308656

    Small molecule inhibitors of Ku70/80 and uses thereof

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  4. US 10308658

    Salt of EGFR inhibitor, crystalline form and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  5. US 10308643

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  6. US 10308638

    Selective alpha-7 nicotinic receptor agonists and methods for making and using them

    The Regents of the University of California · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  7. US 10308698

    Therapeutic targeting of SET1B/compass pathway for treating cancers

    Northwestern University · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  8. US 10308635

    1-sulfonyl piperidine derivatives as modulators of prokineticin receptors

    Takeda Pharmaceutical Company Limited · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  9. US 10308617

    Triazole benzamide derivatives and the compositions and methods of treatment regarding the same

    AN2H DISCOVERY LIMITED · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  10. US 10308608

    Histone deacetylase inhibitors

    BIOMARIN PHARMACEUTICAL INC. · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  11. US 10308708

    Antibodies that neutralize botulinum neurotoxins

    The Regents of the University of California · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  12. US 10308609

    Bicyclic compounds

    Zeno Royalties & Milestones, LLC · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  13. US 10307579

    Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  14. US 10307491

    Liposomal particles comprising biological molecules and uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  15. US 10307484

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  16. US 10307477

    Methods for inducing an immune response against human immunodeficiency virus infection in subjects undergoing antiretroviral treatment

    The United States of America as represented by the Secretary of the Army · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  17. US 10307476

    Genetically stable live attenuated respiratory syncytial virus vaccine and its production

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  18. US 10307437

    Methods for treatment of vascular endothelial dysfunction using nicotinamide mononucleotide

    The Regents of the University of Colorado, a Body Corporate · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  19. US 10307444

    Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells

    Astellas Institute for Regenerative Medicine · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  20. US 10307449

    Compositions of polymeric myrcene

    REGENERA PHARMA LTD. · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  21. US 10307428

    Therapeutic compositions for diabetic symmetrical polyneuropathy

    The Regents of the University of California · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  22. US 10307414

    Pyridinyl and fused pyridinyl triazolone derivatives

    Takeda Pharmaceutical Company Limited · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  23. US 10307410

    Mcl-1 modulating compounds for cancer treatment

    INSTITUT DE CANCEROLOGIE DE L'OUEST RENE GAUDUCHEAU · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  24. US 10307415

    Epimorphic regeneration and related hydrogel delivery systems

    Northwestern University · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.